Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Agita Jeruma"'
Publikováno v:
The Open Infectious Diseases Journal. 10:63-70
Background: Despite effective treatment available from 2016 in Latvia, there are restrictions - only patients with fibrosis (F, Metavir) stage 3 to 4 have access to reimbursed medicines. Some patients obtain generic drugs from India. Objective: The a
Autor:
Wolfgang Vogel, M. Blachier, Lelia Thornton, Wim Laleman, Ieva Tolmane, Antonio Craxì, Mojca Matičič, Hans Van Vlierberghe, Christoph Sarrazin, Laura Harcouet, Joël Mossong, Ilias Gountas, Matthew E. Cramp, Devin Razavi-Shearer, Soo Aleman, Lyudmila Mateva, Ann-Sofi Duberg, Vratislav Nemecek, Jordan Genov, Michael Manns, Anne Øvrehus, Irena Hrstić, Kimberly Murphy, Stefano Vella, Krzysztof Tomasiewicz, Francesco Negro, Nina Weis, Antonio Javier Blasco, Agita Jeruma, Karolin Falconer, Danute Speiciene, Jonas Valantinas, Jose Luis Calleja, Jan Sperl, Gabor Horvath, Filipe Calinas, Peter Jarcuska, Jerneja Videčnik-Zorman, Ivan Schréter, Kathryn Razavi-Shearer, Christophe Moreno, Sergeja Gregorčič, Angelos Hatzakis, Pierre Van Damme, Riina Salupere, Massimo Colombo, Robert J. de Knegt, Peter J Smit, Dijana Nonkovic, Daniela K van Santen, Waldemar Halota, Rui Sarmento-Castro, Jean-Michel Delile, Suzanne Norris, Vana Sypsa, Robert Flisiak, Carole Seguin-Devaux, Martin Lagging, Liana Gheorghe, Mihály Makara, Javier García-Samaniego, Christophe Hézode, Jennifer Kieran, Marian Oltman, Peter Stärkel, Victor de Ledinghen, Pablo Lázaro, Stefan Zeuzem, E. A. Croes, Patrick Hoffmann, Matti Maimets, Francesco Saverio Mennini, Kostas Athanasakis, Chris Estes, Stephen D. Ryder, Sarah Robbins, Françoise Roudot-Thoraval, Martin Kåberg, Kaarlo Simojoki, Sona Frankova, Adrian Goldis, Marietta Simonova, Kyriakos Souliotis, Ken Pasini, Homie Razavi, Rui Tato Marinho, Sarah Blach, Pavol Kristian, Rumiana Mitova, Loreta A. Kondili, Maria Buti, Helen Nde, Boris Lukšić, Henrik Krarup, Dominique Vandijck, Henk W. Reesink, David A. M. C. van de Vijver, Iskren Kotzev, Jessie Gunter, Adriaan J. van der Meer, Martti Färkkilä, Baiba Rozentale, Perttu Arkkila, Krasimir Antonov, Jan Gerstoft, Béla Hunyady, Peer Brehm Christensen, Ivane Gamkrelidze, Valentina Liakina, Michael Gschwantler, Deian Jelev, Tatjana Reic, George V. Papatheodoridis, Jonathan Schmelzer, Daniel Struck
Publikováno v:
Krarup, H & European Union HCV Collaborators 2017, ' Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 5, pp. 325-336 . https://doi.org/10.1016/S2468-1253(17)30045-6
Lancet Gastroenterology & Hepatology, 2(5), 325-336. Elsevier Ltd.
The Lancet Gastroenterology & Hepatology, Vol. 2, No 5 (2017) pp. 325-336
Lancet gastroenterology & hepatology
The lancet. Gastroenterology & hepatology, 2(5), 325-336. HANLEY & BELFUS-ELSEVIER INC
Øvrehus, A L H & European Union HCV Collaborators 2017, ' Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 5, pp. 325-336 . https://doi.org/10.1016/S2468-1253(17)30045-6
Lancet Gastroenterology & Hepatology, 2(5), 325-336. Elsevier Ltd.
The Lancet Gastroenterology & Hepatology, Vol. 2, No 5 (2017) pp. 325-336
Lancet gastroenterology & hepatology
The lancet. Gastroenterology & hepatology, 2(5), 325-336. HANLEY & BELFUS-ELSEVIER INC
Øvrehus, A L H & European Union HCV Collaborators 2017, ' Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 5, pp. 325-336 . https://doi.org/10.1016/S2468-1253(17)30045-6
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting antiviral therapies began in 2014. WHO targets are to achieve a 65% red
Autor:
Katazyna Polubenko, Arvydas Ambrozaitis, Edita Kazenaite, Daiva Radzisauskiene, Evelina Mockiene, Jolita Jakutiene, Ieva Tolmane, Ligita Jancoriene, Agita Jeruma, Arida Buivydiene
Publikováno v:
Hepatitis monthly / Tehran Hepatitis Center, Amsterdam : Kowsar publishing, 2018, vol. 18, no 1, art. no e62105, [p. 1-10]
Background: The current international multicentre open-label, uncontrolled, real-world retrospective study aimed at evaluating the effectiveness and safety of ombitasvir / paritaprevir / ritonavir + dasabuvir ± ribavirin (3D therapy) in treatment-na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d24bd451d493005ca6ed8ef17117013c
https://repository.vu.lt/VU:ELABAPDB26435413&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB26435413&prefLang=en_US
Global prevalence and genotype distribution of hepatitis C virus infection in 2015:a modelling study
Autor:
Hans Van Vlierberghe, Soo Aleman, Naveed Z. Janjua, Henry Lik-Yuen Chan, Olufunmilayo A. Lesi, Irena Hrstić, Abdullah M. Assiri, William Rosenberg, Moon sing Lai, Vladimir Chulanov, Jan Sperl, Beat Müllhaupt, Michael Manns, William Sievert, Sabahattin Kaymakoglu, Cesar Yaghi, Evy Yunihastuti, Pierre Van Damme, Jon G. Jonasson, Antonio Javier Blasco, Young Sik Kim, S. Olafsson, Rohani Jahis, Christoph Sarrazin, Manik Sharma, Aasim Yusuf, Omer Hajelssedig, Javier García-Samaniego, Boris Lukšić, Peter Stärkel, Stefan Zeuzem, Stephen Oguche, E. A. Croes, Abdullah S. Alghamdi, Richard Njouom, CE Omuemu, Carlos E Brandão Mello, Adam Mahomed, Behzad Hajarizadeh, Ogu Omede, Said A. Al-Busafi, Sarah Robbins, Peer Brehm Christensen, Ammal M. Metwally, Béla Hunyady, Gamal Esmat, Ivane Gamkrelidze, Maheeba Abdulla, Suzanne Norris, Sarah Blach, Harald Hofer, Maria C Mendes Correa, Devin Razavi-Shearer, Matti Maimets, Chien-Jen Chen, Peter Jarcuska, Marian Oltman, Francesco Negro, Ilias Gountas, Ayman Yosry, Sona Frankova, Adrian Goldis, Laurentius A. Lesmana, Ivan Schréter, Danute Speiciene, Kevork M. Peltekian, Berhane Redae, Stuart K. Roberts, Valentina Liakina, Seyed M Alavian, Wai-cheung C Lao, Ziv Ben-Ari, Imad Al Ghazzawi, Cheryl Brunton, Rudolf E. Stauber, Akram Khan, Tung-Hung Su, Manal H El-Sayed, Kimberly Murphy, Kyriakos Souliotis, Adriana Vince, Ramazan Idilman, Christophe Moreno, Angelos Hatzakis, Lewis R. Roberts, Richard Phillips, Jason Grebely, Michael Gschwantler, Hugo Cheinquer, Vana Sypsa, Samir Shah, Wolfgang Vogel, M. Blachier, Abate Bane, Henri Leleu, Saeed Hamid, Ohene Opare-Sem, Hamad Al-Romaihi, Wan-Long Chuang, Alexander J. Thompson, Agita Jeruma, Robert Flisiak, Catherine A.M. Stedman, Ingo van Thiel, Carole Seguin-Devaux, Jonathan Schmelzer, Juan F.Sanchez Avila, Rui Tato Marinho, Muhammad S. Memon, Nina Weis, Rosmawati Mohamed, Florian Bihl, Moon Seok Choi, David Kershenobich, Vic Arendt, Yee Tak Hui, Mei Hsuan Lee, N. N. Pimenov, Saad Al Kaabi, Ken Pasini, Henrik Krarup, Stefan Mauss, Shahin Merat, Khalid Al Namaani, Rong-Nan Chien, Perttu Arkkila, Henk W. Reesink, Françoise Roudot-Thoraval, Paul Marotta, Shirley Owusu-Ofori, Fadi H. Mourad, Abdul Rahman Bizri, Chris Estes, Heiner Wedemeyer, Faisal M. Sanai, Mihály Makara, Stephen D. Ryder, Mel Krajden, Laura Cisneros, Adriaan J. van der Meer, Eli Zuckerman, Matthew E. Cramp, Rui Sarmento-Castro, Magnus Gottfredsson, Gregory J. Dore, Huma Qureshi, Yasser Kamel, Olga Sagalova, Rifaat Safadi, Wim Laleman, Solomon Obekpa, Karolin Falconer, Edward Gane, Philip Bruggmann, Fernando Bessone, Jia-Horng Kao, Daniel Lavanchy, Riina Salupere, Anne Øvrehus, Ulus Salih Akarca, Monique Andersson, Man-Fung Yuen, Ala I. Sharara, Olav Dalgard, Homie Razavi, Gamal Shiha, Paulo R. Ferreira, George V. Papatheodoridis, Anatoly Shevaldin, Jawad Khamis, Waseem Hamoudi, Kathryn Razavi-Shearer, Vincent Ws Wong, Loreta A. Kondili, Maria Lucia Gomes Ferraz, Wasim Jafri, Pablo Lázaro, Faisal Abaalkhail, David H. Muljono, Youssif Al Serkal, Imam Waked, Zaher Koutoubi, Oidov Baatarkhuu, Nahum Méndez-Sánchez, Abraham O. Malu, Daniel Struck, Helen Nde, Alnoor Ramji, Ahmed Abdou, Antoine Abou Rached, Michael Li, Diana Nonković, Jorge Daruich, Ezequiel Ridruejo, Gül Ergör, Ann-Sofi Duberg, Krzysztof Tomasiewicz, Filipe Calinas, Hossein Poustchi, Layla Al-Dabal, Jessie Gunter, Mark W. Sonderup, Colm Bergin, Mario G. Pessoa, Jonas Valantinas, Asad Chaudhry, Junko Tanaka, Tsendsuren S. Oyunsuren, Soek Siam Tan, Vivek A. Saraswat, Young-Suk Lim, Ibrahim Altraif, Victor de Ledinghen, Faryal Al Lawati, Mette Rye Clausen, Ieva Tolmane, Antonio Craxì, Abdulrahman Aljumah, Elmoubashar Farag, Inka Aho, Sayed Himatt, Nishi Prabdial-Sing
Publikováno v:
Christensen, P B, Øvrehus, A L H & The Polaris observatoriy HCV collaborators 2017, ' Global prevalence and genotype distribution of hepatitis C virus infection in 2015 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 3, pp. 161–176 . https://doi.org/10.1016/S2468-1253(16)30181-9
LANCET GASTROENTEROLOGY & HEPATOLOGY
The Lancet Gastroenterology & Hepatology, Vol. 2, No 3 (2017) pp. 161-176
Krarup, H & Polaris Observatory HCV Collaborators 2017, ' Global prevalence and genotype distribution of hepatitis C virus infection in 2015 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 3, pp. 161-176 . https://doi.org/10.1016/S2468-1253(16)30181-9
LANCET GASTROENTEROLOGY & HEPATOLOGY
The Lancet Gastroenterology & Hepatology, Vol. 2, No 3 (2017) pp. 161-176
Krarup, H & Polaris Observatory HCV Collaborators 2017, ' Global prevalence and genotype distribution of hepatitis C virus infection in 2015 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 3, pp. 161-176 . https://doi.org/10.1016/S2468-1253(16)30181-9
WOS: 000426979400014
PubMed ID: 28404132
Background The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the recent launch of direc
PubMed ID: 28404132
Background The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the recent launch of direc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91fa1586aecb1dffed87aa24333582a6
https://portal.findresearcher.sdu.dk/da/publications/cdef7f82-202a-4bdc-9ca9-90196ff4240b
https://portal.findresearcher.sdu.dk/da/publications/cdef7f82-202a-4bdc-9ca9-90196ff4240b
Autor:
M. T. Barakat, N. Nugrahini, Andri Sanityoso Sulaiman, S. El Khoury, Béla Hunyady, Y. Al Serkal, Liana Gheorghe, E. S. El Hassan, K. Saeed, M. Siddiq, H. Tarifi, A. Abdou, Homie Razavi, Fadi H. Mourad, Abdul Rahman Bizri, Do Young Kim, Matti Maimets, Devin Razavi-Shearer, S. Gregorcic, Ibrahim Altraif, Chris Estes, A. Salamat, Hamad I. Al-Ashgar, Riina Salupere, Sarah Blach, R. Husni, A. Sibley, F. Al Hosani, P. Aldins, S. Alawadhi, A. Baqir, S. Priohutomo, Mihály Makara, A. Abourached, A. Löve, Ieva Tolmane, Saeed Hamid, B. Karlsdottir, Adrian Goldis, Abdulrahman Aljumah, Samsuridjal Djauzi, Almoutaz Hashim, Laurentius A. Lesmana, Khalid Alswat, Jon G. Jonasson, Danute Speiciene, Young-Suk Lim, Arif Nawaz, M. Taha, R. Al-Hakeem, Abdullah S. Alghamdi, Rino Alvani Gani, Young Seok Kim, Abdullah M. Assiri, J. Videčnik-Zorman, A. Al Rifai, A. Sanityoso Sulaiman, Muhammad S. Memon, H. Fridjonsdottir, M. A. Al Mulla, Faisal M. Sanai, Faisal Abaalkhail, L. Al-Dabal, R. A. Sayegh, A. M. Siddiqui, Gabor Horvath, Moon Suk Choi, Cesar Yaghi, M. Sadik, Irsan Hasan, A. Almessabi, S. Fakhry, Zaigham Abbas, Ala I. Sharara, Evy Yunihastuti, Jacques E Mokhbat, David H. Muljono, Jonas Valantinas, Asad Chaudhry, K. Al Jaberi, H. Al Quraishi, B. Sigurdardottir, Altaf Alam, Mohamed A. Babatin, N. Andrea, F. Al Braiki, Kathryn Razavi-Shearer, Reza Malekzadeh, H. Qureshi, G. Sigmundsdottir, Marwa Sultan, Jonathan Schmelzer, Javed Iqbal Farooqi, Mojca Matičič, Junko Tanaka, S. Olafsson, Behzad Hajarizadeh, Shahin Merat, M. Alzaabi, Valentina Liakina, Adel Alqutub, Seyed M Alavian, G. Tayyab, M. Al Khatry, T. Diab, M. Ud Din, Jessie Gunter, Kwang Hyub Han, Faleh Z. Al-Faleh, Bader Faiyaz Zuberi, Wasim Jafri, P. Rassam, Magnus Gottfredsson, Baiba Rozentale, Agita Jeruma, A. Ghafoor Khan, M. Umar, Ottar M. Bergmann, Z. Koutoubi, M. A. Yusuf
Publikováno v:
Journal of viral hepatitis. 22
The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries in Europe, the Middle East and Asia, and the relative impact of two scenarios was considered: increased treatment efficacy while holding the annual number of treated pa
Autor:
Ligita Jančorienė, Baiba Rozentāle, Ieva Tolmane, Agita Jēruma, Riina Salupere, Arida Buivydienė, Jonas Valantinas, Limas Kupčinskas, Jolanta Šumskienė, Eglė Čiupkevičienė, Arvydas Ambrozaitis, Olga Golubovska, Larysa Moroz, Robert Flisiak, Borys Bondar
Publikováno v:
Medicina, Vol 59, Iss 9, p 1577 (2023)
Background and objectives: Since 2013, highly effective direct-acting antiviral (DAA) treatment for chronic hepatitis C (CHC) has become available, with cure rates exceeding 95%. For the choice of optimal CHC treatment, an assessment of the hepatitis
Externí odkaz:
https://doaj.org/article/2ea1e693a55e415592eb97627adef832
Publikováno v:
Virology & Mycology.
Introduction: 1,7% of the population of Latvia in 2008 was HCV RNA positive, thus approximately 38 thousands required the CHC antiviral therapy. The objective of the study was to evaluate some biochemical and immunogenetic parameters allowing predict
Autor:
Altaf Alam, K. Saeed, N. Nugrahini, Fadi H. Mourad, Andri Sanityoso Sulaiman, Abdul Rahman Bizri, Jon G. Jonasson, Liana Gheorghe, S. Alawadhi, Ala I. Sharara, Sarah Blach, Rino Alvani Gani, Do Young Kim, M. Alzaabi, Young Seok Kim, Matti Maimets, S. Priohutomo, A. Löve, Saeed Hamid, Abdullah M. Assiri, H. Al Quraishi, Adel Alqutub, G. Tayyab, Junko Tanaka, H. Qureshi, A. Salamat, P. Aldins, M. S. Choi, M. T. Barakat, Reza Malekzadeh, M. Sadik, Kwang Hyub Han, Young-Suk Lim, J. Videčnik-Zorman, A. Abdou, Jacques E Mokhbat, Zaigham Abbas, Khalid Alswat, G. Sigmundsdottir, B. Karlsdottir, Marwa Sultan, K. Al Jaberi, Devin Razavi-Shearer, A. Al Rifai, Chris Estes, Abdullah S. Alghamdi, A. Sanityoso Sulaiman, Béla Hunyady, F. Al Braiki, B. Sigurdardottir, Ieva Tolmane, Kathryn Razavi-Shearer, S. El Khoury, Gabor Horvath, Y. Al Serkal, M. Taha, Hamad I. Al-Ashgar, Cesar Yaghi, Abdulrahman Aljumah, Danute Speiciene, Riina Salupere, Irsan Hasan, S. Fakhry, Homie Razavi, Evy Yunihastuti, F. Al Hosani, M. A. Al Mulla, Faisal M. Sanai, Mohamed A. Babatin, N. Andrea, L. Al-Dabal, S. Gregorcic, Arif Nawaz, R. Al-Hakeem, E. S. El Hassan, R. Husni, M. Siddiq, David H. Muljono, Adrian Goldis, A. Almessabi, Jonathan Schmelzer, Mojca Maticic, Laurentius A. Lesmana, A. Baqir, Ibrahim Altraif, Faisal Abaalkhail, Shahin Merat, Mihály Makara, A. Abourached, Jonas Valantinas, Asad Chaudhry, T. Diab, M. Ud Din, Muhammad S. Memon, Jessie Gunter, R. A. Sayegh, Seyed Moayed Alavian, A. M. Siddiqui, H. Fridjonsdottir, Bader Faiyaz Zuberi, M. Umar, Magnus Gottfredsson, Baiba Rozentale, Agita Jeruma, Samsuridjal Djauzi, Almoutaz Hashim, A. Ghafoor Khan, Ottar M. Bergmann, Z. Koutoubi, M. A. Yusuf, H. Tarifi, A. Sibley, Faleh Z. Al-Faleh, Wasim Jafri, P. Rassam, J. I. Farooqi, S. Olafsson, Behzad Hajarizadeh, Valentina Liakina, M. Al Khatry
Publikováno v:
Journal of viral hepatitis
Razavi, H, Waked, I, Sarrazin, C, Myers, R P, Idilman, R, Calinas, F, Vogel, W, Mendes Correa, M C, Hézode, C, Lázaro, P, Akarca, U, Aleman, S, Balık, I, Berg, T, Bihl, F, Bilodeau, M, Blasco, A J, Brandão Mello, C E, Bruggmann, P, Buti, M, Calleja, J L, Cheinquer, H, Christensen, P B, Clausen, M, Coelho, H S M, Cramp, M E, Dore, G J, Doss, W, Duberg, A S, El-Sayed, M H, Ergör, G, Esmat, G, Falconer, K, Félix, J, Ferraz, M L G, Ferreira, P R, Frankova, S, García-Samaniego, J, Gerstoft, J, Giria, J A, Gonçales, F L, Gower, E, Gschwantler, M, Guimarães Pessôa, M, Hindman, S J, Hofer, H, Husa, P, Kåberg, M, Kaita, K D E, Kautz, A, Kaymakoglu, S, Krajden, M, Krarup, H, Laleman, W, Lavanchy, D, Marinho, R T, Marotta, P, Mauss, S, Moreno, C, Murphy, K, Negro, F, Nemecek, V, Örmeci, N, Øvrehus, A L H, Parkes, J, Pasini, K, Peltekian, K M, Ramji, A, Reis, N, Roberts, S K, Rosenberg, W M, Roudot-Thoraval, F, Ryder, S D, Sarmento-Castro, R, Semela, D, Sherman, M, Shiha, G E, Sievert, W, Sperl, J, Stärkel, P, Stauber, R E, Thompson, A J, Urbanek, P, Van Damme, P, van Thiel, I, Van Vlierberghe, H, Vandijck, D, Wedemeyer, H, Weis, N, Wiegand, J, Yosry, A, Zekry, A, Cornberg, M, Müllhaupt, B & Estes, C 2014, ' The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm ', Journal of Viral Hepatitis, vol. 21, no. Suppl 1, pp. 34-59 . https://doi.org/10.1111/jvh.12248
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Razavi, H, Waked, I, Sarrazin, C, Myers, R P, Idilman, R, Calinas, F, Vogel, W, Mendes Correa, M C, Hézode, C, Lázaro, P, Akarca, U, Aleman, S, Balık, I, Berg, T, Bihl, F, Bilodeau, M, Blasco, A J, Brandão Mello, C E, Bruggmann, P, Buti, M, Calleja, J L, Cheinquer, H, Christensen, P B, Clausen, M, Coelho, H S M, Cramp, M E, Dore, G J, Doss, W, Duberg, A S, El-Sayed, M H, Ergör, G, Esmat, G, Falconer, K, Félix, J, Ferraz, M L G, Ferreira, P R, Frankova, S, García-Samaniego, J, Gerstoft, J, Giria, J A, Gonçales, F L, Gower, E, Gschwantler, M, Guimarães Pessôa, M, Hindman, S J, Hofer, H, Husa, P, Kåberg, M, Kaita, K D E, Kautz, A, Kaymakoglu, S, Krajden, M, Krarup, H, Laleman, W, Lavanchy, D, Marinho, R T, Marotta, P, Mauss, S, Moreno, C, Murphy, K, Negro, F, Nemecek, V, Örmeci, N, Holm, A L, Parkes, J, Pasini, K, Peltekian, K M, Ramji, A, Reis, N, Roberts, S K, Rosenberg, W M, Roudot-Thoraval, F, Ryder, S D, Sarmento-Castro, R, Semela, D, Sherman, M, Shiha, G E, Sievert, W, Sperl, J, Stärkel, P, Stauber, R E, Thompson, A J, Urbanek, P, Van Damme, P, van Thiel, I, Van Vlierberghe, H, Vandijck, D, Wedemeyer, H, Weis, N, Wiegand, J, Yosry, A, Zekry, A, Cornberg, M, Müllhaupt, B & Estes, C 2014, ' The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm ', Journal of Viral Hepatitis, vol. 21, no. Suppl 1, pp. 34–59 . https://doi.org/10.1111/jvh.12248
Journal of Viral Hepatitis, Vol. 21 Suppl 1 (2014) pp. 34-59
Razavi, H, Waked, I, Sarrazin, C, Myers, R P, Idilman, R, Calinas, F, Vogel, W, Mendes Correa, M C, Hézode, C, Lázaro, P, Akarca, U, Aleman, S, Balık, I, Berg, T, Bihl, F, Bilodeau, M, Blasco, A J, Brandão Mello, C E, Bruggmann, P, Buti, M, Calleja, J L, Cheinquer, H, Christensen, P B, Clausen, M, Coelho, H S M, Cramp, M E, Dore, G J, Doss, W, Duberg, A S, El-Sayed, M H, Ergör, G, Esmat, G, Falconer, K, Félix, J, Ferraz, M L G, Ferreira, P R, Frankova, S, García-Samaniego, J, Gerstoft, J, Giria, J A, Gonçales, F L, Gower, E, Gschwantler, M, Guimarães Pessôa, M, Hindman, S J, Hofer, H, Husa, P, Kåberg, M, Kaita, K D E, Kautz, A, Kaymakoglu, S, Krajden, M, Krarup, H, Laleman, W, Lavanchy, D, Marinho, R T, Marotta, P, Mauss, S, Moreno, C, Murphy, K, Negro, F, Nemecek, V, Örmeci, N, Øvrehus, A L H, Parkes, J, Pasini, K, Peltekian, K M, Ramji, A, Reis, N, Roberts, S K, Rosenberg, W M, Roudot-Thoraval, F, Ryder, S D, Sarmento-Castro, R, Semela, D, Sherman, M, Shiha, G E, Sievert, W, Sperl, J, Stärkel, P, Stauber, R E, Thompson, A J, Urbanek, P, Van Damme, P, van Thiel, I, Van Vlierberghe, H, Vandijck, D, Wedemeyer, H, Weis, N, Wiegand, J, Yosry, A, Zekry, A, Cornberg, M, Müllhaupt, B & Estes, C 2014, ' The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm ', Journal of Viral Hepatitis, vol. 21, no. Suppl 1, pp. 34-59 . https://doi.org/10.1111/jvh.12248
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Razavi, H, Waked, I, Sarrazin, C, Myers, R P, Idilman, R, Calinas, F, Vogel, W, Mendes Correa, M C, Hézode, C, Lázaro, P, Akarca, U, Aleman, S, Balık, I, Berg, T, Bihl, F, Bilodeau, M, Blasco, A J, Brandão Mello, C E, Bruggmann, P, Buti, M, Calleja, J L, Cheinquer, H, Christensen, P B, Clausen, M, Coelho, H S M, Cramp, M E, Dore, G J, Doss, W, Duberg, A S, El-Sayed, M H, Ergör, G, Esmat, G, Falconer, K, Félix, J, Ferraz, M L G, Ferreira, P R, Frankova, S, García-Samaniego, J, Gerstoft, J, Giria, J A, Gonçales, F L, Gower, E, Gschwantler, M, Guimarães Pessôa, M, Hindman, S J, Hofer, H, Husa, P, Kåberg, M, Kaita, K D E, Kautz, A, Kaymakoglu, S, Krajden, M, Krarup, H, Laleman, W, Lavanchy, D, Marinho, R T, Marotta, P, Mauss, S, Moreno, C, Murphy, K, Negro, F, Nemecek, V, Örmeci, N, Holm, A L, Parkes, J, Pasini, K, Peltekian, K M, Ramji, A, Reis, N, Roberts, S K, Rosenberg, W M, Roudot-Thoraval, F, Ryder, S D, Sarmento-Castro, R, Semela, D, Sherman, M, Shiha, G E, Sievert, W, Sperl, J, Stärkel, P, Stauber, R E, Thompson, A J, Urbanek, P, Van Damme, P, van Thiel, I, Van Vlierberghe, H, Vandijck, D, Wedemeyer, H, Weis, N, Wiegand, J, Yosry, A, Zekry, A, Cornberg, M, Müllhaupt, B & Estes, C 2014, ' The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm ', Journal of Viral Hepatitis, vol. 21, no. Suppl 1, pp. 34–59 . https://doi.org/10.1111/jvh.12248
Journal of Viral Hepatitis, Vol. 21 Suppl 1 (2014) pp. 34-59
Gilead Sciences The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modelling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. in
Autor:
Ludmila Viksna, Valentina Sondore, Gunta Sture, Andrejs Ivanovs, Jazeps Keiss, Baiba Rozentale, Agita Jeruma
Publikováno v:
Virology & Mycology.
Introduction: Pegilated interferon alpha-2a 40KD (Pegasys?) is registered in European Union, and is indicated for the treatment of HBeAg positive or HBeAg negative chronic hepatitis B in adult patients with compensated liver disease, evidence of vira
Autor:
Valentina Sondore, Jazeps Keiss, Ilze Strumfa, Baiba Rozentale, Agita Jeruma, Peteris Prieditis, Ludmila Viksna, Arturs Sochnevs
Publikováno v:
Liver Biopsy
During the past 60 years the role and importance of liver biopsy have changed. In 1950s the introduction of liver puncture biopsy was absolute innovation, e.g. in Latvia, and had an invaluable significance. The possibility to compare and/or oppose al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384da1bf697ecd208c955d432f543345
http://www.intechopen.com/articles/show/title/noninvasive-alternatives-to-liver-biopsy
http://www.intechopen.com/articles/show/title/noninvasive-alternatives-to-liver-biopsy